论文部分内容阅读
Vandetanib(1)is a kind of tryrosine kinase inhibitors.It is a potent inhibitor of VEGF RTK and also has some activity against epidermal growth factor(EGF)RTK[1].It inhibits the effects of VEGF and is of interest for its antiangiogenic and/or vascular permeability effect[2-3].